Department of General Surgery, İstanbul University, İstanbul Medical Faculty, İstanbul-Türkiye.
Department of Radiology, İstanbul University, İstanbul Medical Faculty, İstanbul-Türkiye.
Ulus Travma Acil Cerrahi Derg. 2024 Jan;30(1):38-42. doi: 10.14744/tjtes.2023.23793.
Although true splenic artery aneurysms (SAA) are rare, due to advancements in imaging techniques, they are seen more frequently. The aim of this study is to present our strategy of managing patients with SAA.
Retrospectively, 13 patients who were treated in a tertiary university care center between 2012 and 2020 were included. Their demographic, clinical information, and post-operative complications were analyzed.
Seven male and six female patients were evaluated between the ages of 27 and 73. The mean age was 49.8±13.2. The diameter of the aneurysm was between 17 and 80 mm with a mean range of 31.5±16 mm. Seven patients were treated with endovascular interventions (EV). Two patients were referred to surgery with failed attempt of EV, but patients refused surgery and were followed up consequently. Patients who had larger aneurysms with an increased risk of rupture underwent aneurysmectomy and splenectomy. Conservative management was decided on two patients initially: A patient who was previously operated on for a sigmoid colon tumor, and had an aneurysm size of 15 mm and another patient with a surgical history of thoracic aortic dissection with an aneurysm size of 18 mm. One patient who underwent surgery had post-operative pancreatic fistula and was treated with percutaneous drainage. The treatment of the remaining 12 patients was completed without any further complications.
Splenic artery aneurysm treatment should be individualized. Endovascular treatment can be considered for patients with stable aneurysms larger than 2 cm in the elective setting. Open surgical treatment should be considered in patients with ruptured SAA or hemodynamically unstable, complicated patients.
尽管真性脾动脉瘤(SAA)较为罕见,但由于影像学技术的进步,其检出率逐渐增高。本研究旨在介绍我们对 SAA 患者的治疗策略。
回顾性分析 2012 年至 2020 年间在一家三级大学附属医院接受治疗的 13 例 SAA 患者。分析了他们的人口统计学、临床资料和术后并发症。
纳入 7 例男性和 6 例女性患者,年龄 2773 岁,平均年龄 49.8±13.2 岁。动脉瘤直径 1780mm,平均范围 31.5±16mm。7 例患者接受了血管内介入治疗(EV)。2 例患者 EV 治疗失败后转手术治疗,但患者拒绝手术,随后进行了随访。对于有破裂风险的较大动脉瘤患者行动脉瘤切除术和脾切除术。2 例患者最初采用保守治疗:1 例患者既往因乙状结肠癌行手术治疗,动脉瘤大小为 15mm;另 1 例患者因胸主动脉夹层行手术治疗,动脉瘤大小为 18mm。1 例手术患者术后出现胰瘘,行经皮引流治疗。其余 12 例患者的治疗均顺利完成,无其他并发症。
脾动脉瘤的治疗应个体化。对于稳定的、直径大于 2cm 的择期患者,可考虑行 EV 治疗。对于破裂的 SAA 或血流动力学不稳定、合并症复杂的患者,应考虑行开放手术治疗。